journal article·2022-09-30Open access

Solubilized chlorin e6-layered double hydroxide complex for anticancer photodynamic therapy

Young-um Jo, HyunJune Sim, Chung-Sung Lee, Kyoung Sub Kim, Kun Na

Biomaterials Research· Volume 26· Issue 1

Abstract

Abstract Background Layered double hydroxides (LDHs) are one type of 2-dimensional material with unique structure and strongly positive surface charge. Particularly, LDHs can be exfoliated by mono-layered double hydroxides (MLHs) as a single layer, showing an increased surface area. Therefore, there is a large focus on LDHs for drug delivery applications. Furthermore, most photosensitizers are hydrophobic that they cannot be soluble in aqueous solvents. Herein, we designed a simple way to solubilize hydrophobic photosensitizers by MLH with electrostatic interactions for anticancer photodynamic therapy (PDT), which has tremendous therapeutic advantages. The photosensitizer solubilized via loading on the MLH exhibited fluorescence and singlet oxygen-generation activities in aqueous solvent without chemical modification, resulting in photo-mediated anticancer treatment. Methods Negatively charged hydrophobic photosensitizers, chlorin e6 (Ce6) were solubilized by loading on the MLHs through the electrostatic interaction between positively charged MLHs. MLH/Ce6 complexes evaluated for physico-chemical characterization, pH-sensitive release property, in vitro photocytotoxicity, and in vivo tumor ablation. Results The photosensitizer solubilized via MLH exhibited fluorescence intensity and singlet-oxygen generation activities in aqueous solvent without chemical modification, resulting photocytotoxicity in cancer cells. The encapsulation efficiency of Ce6 increased to 21.2% through MLH compared to 0.6% when using LDH. In tumor-bearing mice, PDT with solubilized MLH/Ce6 indicated a tumor-suppressing effect approximately 3.4-fold greater than that obtained when Ce6 was injected alone. Conclusions This study provided the solubilized Ce6 by the MLH in a simple way without chemical modification. We demonstrated that MLH/Ce6 complexes would have a great potential for anticancer PDT.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Gyeonggi-do, Bucheon-si 14662, Republic of Korea.

Department of Biomedical-Chemical Engineering, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Gyeonggi-do, Bucheon-si 14662, Republic of Korea.

Department of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Chungcheongnam-do 31460, Asan-si, Republic of Korea.

Funding

Ministry of Science and ICT, South Korea

References (36)

Show source-provided references
1. 10.1039/C4CS00160E10.1039/C4CS00160E ↗
2. 10.1039/C4CC07715F10.1039/C4CC07715F ↗
3. 10.1016/j.clay.2013.01.00210.1016/j.clay.2013.01.002 ↗
4. 10.1016/j.jhazmat.2017.05.04610.1016/j.jhazmat.2017.05.046 ↗
5. 10.1021/acsami.7b0680310.1021/acsami.7b06803 ↗
6. 10.1002/cctc.20100012610.1002/cctc.201000126 ↗
7. 10.1016/j.watres.2013.06.03910.1016/j.watres.2013.06.039 ↗
8. 10.1016/j.jcis.2010.07.05310.1016/j.jcis.2010.07.053 ↗
9. 10.1002/smtd.20190034310.1002/smtd.201900343 ↗
10. 10.1039/C7NR01771E10.1039/C7NR01771E ↗
11. 10.1007/s00396005030310.1007/s003960050303 ↗
12. 10.1021/cr200434v10.1021/cr200434v ↗
13. 10.1039/C7CS00318H10.1039/C7CS00318H ↗
14. 10.1007/s12274-017-1619-y10.1007/s12274-017-1619-y ↗
15. 10.1002/advs.20180115510.1002/advs.201801155 ↗
16. 10.1021/cr500419810.1021/cr5004198 ↗
17. 10.1002/chem.20130420210.1002/chem.201304202 ↗
18. 10.1039/C4CC00746H10.1039/C4CC00746H ↗
19. 10.1002/mabi.20140036110.1002/mabi.201400361 ↗
20. 10.1016/j.jphotobiol.2016.03.05810.1016/j.jphotobiol.2016.03.058 ↗
21. 10.1039/C5CC09239F10.1039/C5CC09239F ↗
22. 10.1002/adhm.20150062210.1002/adhm.201500622 ↗
23. 10.1016/j.biomaterials.2015.11.01410.1016/j.biomaterials.2015.11.014 ↗
24. 10.1007/s12272-020-01214-510.1007/s12272-020-01214-5 ↗
25. 10.1016/j.ejps.2011.04.00410.1016/j.ejps.2011.04.004 ↗
26. 10.1039/B915149B10.1039/B915149B ↗
27. 10.1016/j.ejps.2011.09.01610.1016/j.ejps.2011.09.016 ↗
28. 10.1039/b416913a10.1039/b416913a ↗
29. 10.1016/j.biomaterials.2018.05.01510.1016/j.biomaterials.2018.05.015 ↗
30. 10.1016/j.biomaterials.2014.09.01410.1016/j.biomaterials.2014.09.014 ↗
31. 10.1021/cm703602t10.1021/cm703602t ↗
32. 10.1038/s41467-021-21071-010.1038/s41467-021-21071-0 ↗
33. 10.3390/cancers1210279310.3390/cancers12102793 ↗
34. 10.1016/j.jconrel.2014.03.03010.1016/j.jconrel.2014.03.030 ↗
35. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
36. 10.1016/j.ejpb.2008.11.01010.1016/j.ejpb.2008.11.010 ↗